🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆
Updated 12 Aug 2026 · ClinicalTrials.gov

Clinical Trials in China

Every active and recruiting clinical study with an investigative site in China — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

106
Recruiting now
166
Active studies
Starting soon Phase 2
Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negative Breast Cancer)
Breast Cancer
Sun Yat-sen University · started 2026-11-04
📍 Guangzhou
NCT07255612 on ClinicalTrials.gov ↗
Starting soon
Effects of Different Music Tempos on Feeding Outcomes in Preterm Infants
Music
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · started 2026-09-20
📍 Shanghai
NCT07506811 on ClinicalTrials.gov ↗
Starting soon Phase 2
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma (RRMM)
Excyte Biopharma Ltd · started 2026-09
📍 Beijing
NCT07695740 on ClinicalTrials.gov ↗
Starting soon Phase 1/Phase 2
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
Advanced Solid Tumors Cancer, Pancreatic Ductal Adenocarcinoma, RAS Mutation
Genfleet Therapeutics (Shanghai) Inc. · started 2026-09
📍 Beijing · Guangzhou · Harbin · Zhengzhou · Wuhan · Shenyang
NCT07678593 on ClinicalTrials.gov ↗
Starting soon
Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients
Lung Cancer (NSCLC), Lung Cancer (SCLC)
HAN GUANG · started 2026-08-15
📍 Wuhan
NCT07742800 on ClinicalTrials.gov ↗
Starting soon Phase 2/Phase 3
Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
Acute Ischemic Stroke (AIS)
yifang zhu · started 2026-08-10
📍 Suzhou
NCT07734792 on ClinicalTrials.gov ↗
Starting soon
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter Study
Uterine Fibroids (UF), Microwave Ablation, Ultrasound
Peking University Aerospace Center Hospital · started 2026-08-01
📍 Beijing
NCT07754877 on ClinicalTrials.gov ↗
Starting soon
AI-assisted Rare Disease Diagnosis
Rare Disorders, Rare Diseases
Peking Union Medical College Hospital · started 2026-08-01
📍 Beijing · Cangzhou · Changchun · Dongguan · Foshan · Guiyang
NCT07650799 on ClinicalTrials.gov ↗
Starting soon Phase 3
A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia
Severe Hypertriglyceridemia
Zhejiang Doer Biologics Co., Ltd. · started 2026-08
📍 Beijing
NCT07680829 on ClinicalTrials.gov ↗
Starting soon Phase 1
U96-CAR-T-Cells For R/R B-ALL
Relapsed or Refractory B Cell Leukemia and Lymphoma
The First Affiliated Hospital of Soochow University · started 2026-07-30
📍 Suzhou
NCT07511426 on ClinicalTrials.gov ↗
Recruiting Phase 1
Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in China
Healthy Participants Study
Chengdu Zenitar Biomedical Technology Co., Ltd · started 2026-07-23
📍 Chengdu
NCT07757152 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study to Evaluate the Effects of Low-Fat Meal, High-Fat Meal and Omeprazole Enteric-Coated Tablets on the Pharmacokinetics of ABSK-011 Capsules in Healthy Participants
Healthy Participants
Abbisko Therapeutics Co, Ltd · started 2026-07-21
📍 Wuxi
NCT07700953 on ClinicalTrials.gov ↗
Recruiting
AI-Optimized Single-Feature Recognition Model for Heart Failure
Cardiac Sound, Heart Failure - NYHA II - IV
Vivalink · started 2026-07-16
📍 Hangzhou
NCT07667452 on ClinicalTrials.gov ↗
Starting soon Phase 1
A Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection
Respiratory Syncytial Virus (RSV)
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. · started 2026-07-15
📍 Beijing
NCT07694557 on ClinicalTrials.gov ↗
Starting soon
Stellate Ganglion Block and Prognosis of Neurological Function After Subarachnoid Hemorrhage
Aneurysmal Subarachnoid Hemorrhage, Stellate Ganglion Block, Neurological Prognosis
Beijing Tiantan Hospital · started 2026-06-15
📍 Beijing
NCT07652749 on ClinicalTrials.gov ↗
Starting soon Phase 1/Phase 2
Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease
Wilson's Disease
Lingyi Biotech Co., Ltd. · started 2026-06-15
📍 Hangzhou
NCT07641140 on ClinicalTrials.gov ↗
Recruiting
Probiotic Improve Constipation
Constipation
Wecare Probiotics Co., Ltd. · started 2026-06-10
📍 Suzhou
NCT07462481 on ClinicalTrials.gov ↗
Recruiting
Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System
type1diabetes, CGM, T1D
SiBionics, Co, Ltd · started 2026-06-01
📍 Zibo
NCT07745244 on ClinicalTrials.gov ↗
Starting soon
A Multicenter Registry-Based Study Across the Spectrum of Degenerative Cervical Myelopathy
Degenerative Cervical Myelopathy, Non-myelopathic Degenerative Cervical Cord Compression, Asymptomatic Degenerative Cervical Cord Compression, Cervical Spinal Cord Compression
Wangjing Hospital, China Academy of Chinese Medical Sciences · started 2026-06-01
📍 Beijing
NCT07641699 on ClinicalTrials.gov ↗
Recruiting EARLY_Phase 1
A Study of Dose Escalation of ES502 in Patients With Advanced Pancreatic Cancer
Pancreatic Cancer
Ruijin Hospital · started 2026-05-18
📍 Shanghai
NCT07649928 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Sichuan Baili Pharmaceutical Co., Ltd. · started 2026-05-15
📍 Beijing
NCT07518147 on ClinicalTrials.gov ↗
Starting soon Phase 3
Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer
NSCLC (Advanced Non-small Cell Lung Cancer)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · started 2026-05-01
📍 Beijing
NCT07560358 on ClinicalTrials.gov ↗
Recruiting
Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts
Warts
First Hospital of China Medical University · started 2026-05-01
📍 Shenyang
NCT07534865 on ClinicalTrials.gov ↗
Active
Development and Validation of an AI Foundation Model for Frozen-Section Pathology
Cancer, Intraoperative Pathology, Artificial Intelligence (AI)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · started 2026-04-27
📍 Guangzhou
NCT07708207 on ClinicalTrials.gov ↗
By invitation
Transcutaneous Auricular Vagus Nerve Stimulation for Preventing Acute Kidney Injury in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
Acute Kidney Injury, Cardiac Surgery, Cardiopulmonary Bypass
Sir Run Run Shaw Hospital · started 2026-04-27
📍 Hangzhou
NCT07549243 on ClinicalTrials.gov ↗
Starting soon EARLY_Phase 1
A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases
Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE), Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD), Progressive Multiple Sclerosis (PMS), Relapsed/Refractory Myasthenia Gravis(r/r MS)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · started 2026-04-20
📍 Hefei · Beijing · Wuhan · Taiyuan
NCT07583030 on ClinicalTrials.gov ↗
Recruiting Phase 3
Topical Chlorhexidine Spray for the Prevention of Acute Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma:
Nasopharangeal Cancer
Jiangxi Provincial Cancer Hospital · started 2026-04-01
📍 Nanchang
NCT07559877 on ClinicalTrials.gov ↗
Recruiting
A Study on the Effects of Breathing Exercises and Aerobic Exercise on the Health of Men in Drug Rehabilitation
Disorders, Substance Related
Southwest Medical University · started 2026-04-01
📍 Luzhou
NCT07592195 on ClinicalTrials.gov ↗
Recruiting Phase 3
Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction
Breast Cancer, Breast Reconstruction, Radiation Oncology
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · started 2026-03-27
📍 Beijing
NCT07084519 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
Oesophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC · started 2026-03-27
📍 Beijing · Jinan
NCT07405151 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
A Clinical Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Premature Ovarian Insufficiency
Premature Ovarian Insufficiency
International Peace Maternity and Child Health Hospital · started 2026-03-20
📍 Shanghai
NCT07510139 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Atamparib in Patients With Advanced Solid Tumors
NSCLC Adenocarcinoma, Solid Tumor
Nerviano Medical Sciences (Shanghai) Ltd. · started 2026-03-18
📍 Shanghai
NCT07374419 on ClinicalTrials.gov ↗
Recruiting
A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement
Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
Jiangsu Trulive Medical Co., Ltd · started 2026-03-18
📍 Beijing
NCT07691307 on ClinicalTrials.gov ↗
Recruiting Phase 1
Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP-538 in Healthy Subjects
Health Services Research
Beijing InnoCare Pharma Tech Co., Ltd. · started 2026-03-13
📍 Beijing
NCT07535099 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children
Respiratory Syncytial Virus Infection
Simcere Pharmaceutical Co., Ltd · started 2026-03-11
📍 Xiamen · Changsha · Chengdu · Hangzhou
NCT07402512 on ClinicalTrials.gov ↗
Starting soon Phase 2
Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification
Solid Tumors
Tongji Hospital · started 2026-03-01
📍 Wuhan
NCT07417501 on ClinicalTrials.gov ↗
Recruiting
Basilar Artery Occlusion Chinese Endovascular Registry in Patients With Large-Core Infarct
Basilar Artery Occlusion, Ischemic Stroke, Large Core Infarct
Xuanwu Hospital, Beijing · started 2026-01-31
📍 Beijing
NCT07345702 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors
Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · started 2026-01-22
📍 Beijing · Fuzhou · Meizhou · Shanghai · Chengdu
NCT07269145 on ClinicalTrials.gov ↗
Recruiting Phase 3
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Multiple Sclerosis
Sanofi · started 2026-01-14
📍 Beijing · Chengdu · Jiazhuang
NCT07325292 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of SIM0811 Injection in Healthy Chinese Adult Participants
Health, Subjective
Jiangsu Simcere Pharmaceutical Co., Ltd. · started 2026-01-12
📍 Jinan
NCT07345364 on ClinicalTrials.gov ↗
Recruiting Phase 2
Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-Negative High-Risk Ovarian Cancer: A Multicenter, Non-Randomized, Single-Arm Phase II Clinical Study
Ovarian Cancer Metastatic, Ovarian Cancer Metastatic Recurrent
Jiangsu Cancer Institute & Hospital · started 2026-01-01
📍 Nanjing
NCT07311577 on ClinicalTrials.gov ↗
Recruiting Phase 4
Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial
Coronary Artery Disease (CAD)
Nanjing First Hospital, Nanjing Medical University · started 2026-01-01
📍 Nanjing
NCT07349875 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation
Acute Respiratory Distress Syndrome (ARDS), Acute Lung Injury(ALI), Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome
Shanghai University of Traditional Chinese Medicine · started 2025-12-10
📍 Shanghai
NCT07342205 on ClinicalTrials.gov ↗
Recruiting Phase 3
Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer
Metastatic Pancreatic Cancer
Genfleet Therapeutics (Shanghai) Inc. · started 2025-12-04
📍 Beijing
NCT07262567 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Bristol-Myers Squibb · started 2025-12-03
📍 Beijing · Guangzhou · Shenzhen · Handan · Zhengzhou · Changsha
NCT06979453 on ClinicalTrials.gov ↗
Recruiting
DLL3-Targeted PET/CT in Neuroendocrine Carcinoma
DLL3-expressing Tumors, PET / CT, Neuroendocrine Cancer
The First Affiliated Hospital of Xiamen University · started 2025-12-01
📍 Xiamen
NCT07458906 on ClinicalTrials.gov ↗
Active Phase 2
A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis
Adult Patients With Moderately to Severely Active Ulcerative Colitis
Guangdong Hengrui Pharmaceutical Co., Ltd · started 2025-12-01
📍 Guangzhou
NCT07232576 on ClinicalTrials.gov ↗
Recruiting Phase 2
Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Alexion Pharmaceuticals, Inc. · started 2025-11-26
📍 Baotou · Beijing · Guangzhou · Hangzhou · Nanchang · Shenzhen
NCT07160608 on ClinicalTrials.gov ↗
Recruiting Phase 3
HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer
KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting
Jiangsu HengRui Medicine Co., Ltd. · started 2025-11-21
📍 Shanghai
NCT07232875 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Smoking
Eli Lilly and Company · started 2025-11-03
📍 Beijing · Chengdu · Chongqing · Hangzhou · Linhai · Ningbo
NCT07223840 on ClinicalTrials.gov ↗
Recruiting
A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT
Menin Inhibitors, Acute Leukemia, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy
The First Affiliated Hospital of Soochow University · started 2025-11-01
📍 Suzhou
NCT07559695 on ClinicalTrials.gov ↗
Recruiting Phase 2
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
Muscle Invasive Bladder Cancer (MIBC)
Fujian Medical University Union Hospital · started 2025-10-25
📍 Fuzhou · Putian · Quanzhou · Sanming · Xiamen · Zhangzhou
NCT07296705 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Janssen Research & Development, LLC · started 2025-10-01
📍 Beijing · Changzhou · Cheng Du Shi · Chongqing · Foshan · Fuzhou
NCT07196748 on ClinicalTrials.gov ↗
Recruiting
Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury
Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine · started 2025-10-01
📍 Hangzhou
NCT07263217 on ClinicalTrials.gov ↗
Recruiting Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Plaque Psoriasis
Bristol-Myers Squibb · started 2025-09-22
📍 Bengbu · Beijing · Chongqing · Fuzhou · Guangzhou · Shenzhen
NCT07116967 on ClinicalTrials.gov ↗
Starting soon Phase 2
Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma
Kaposiform Hemangioendothelioma
West China Hospital · started 2025-09-13
📍 Chengdu
NCT07131644 on ClinicalTrials.gov ↗
Active Phase 2
A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of Hepatitis B
Chronic Hepatitis B
Shanghai Argo Biopharmaceutical Co., Ltd. · started 2025-09-02
📍 Hefei · Beijing · Sichuan · Chongqing · Fuzhou · Guangzhou
NCT07135349 on ClinicalTrials.gov ↗
Starting soon
Rapid Detection of Pseudomonas Aeruginosa in Bronchoalveolar Lavage Fluid Using Label-free Single-particle Imaging Technology and Assessment of Post-treatment Efficacy in Patients With Pseudomonas Aeruginosa Infection
Rapid Detection, Pseudomonas Aeruginosa Infection
The First Affiliated Hospital with Nanjing Medical University · started 2025-09-01
📍 Nanjing
NCT06986512 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Akeso · started 2025-08-14
📍 Beijing · Fuzhou · Shijiazhuang · Harbin · Shanghai · Tianjin
NCT07023315 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01)
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Sichuan Baili Pharmaceutical Co., Ltd. · started 2025-08-04
📍 Shanghai
NCT06994195 on ClinicalTrials.gov ↗
Recruiting
Real World Evidence Study of SYN023 in Children Exposed to Rabies
Rabies Post-exposure Prophylaxis
Synermore Biologics (Suzhou) Co., Ltd. · started 2025-08-02
📍 Beijing · Shenzhen · Changsha · Hengyang · Nanchang
NCT07327307 on ClinicalTrials.gov ↗
By invitation
The Effects of Self-Myofascial Release on Physical Fitness and Swing Performance in Male Collegiate Golfers in China
Range of Motion, Articular, Physical Fitness, Golf Specific Performance
Yang Qi · started 2025-08-01
📍 Haikou
NCT07064148 on ClinicalTrials.gov ↗
Starting soon Phase 1/Phase 2
Phase I/II Study of SCTB39G in Advanced Solid Tumours
Advanced Malignant Solid Tumor
Sinocelltech Ltd. · started 2025-07-28
📍 Beijing
NCT07077252 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Multi-CAR T Cell Therapy for Acute Myeloid Leukemia
Acute Myeloid Leukemia
Shenzhen Geno-Immune Medical Institute · started 2025-07-15
📍 Shenzhen
NCT03222674 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
Nasopharyngeal Cancinoma (NPC), Recurrent Nasopharynx Carcinoma, Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University · started 2025-07-09
📍 Guangzhou
NCT06802835 on ClinicalTrials.gov ↗
Recruiting Phase 3
Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Akeso · started 2025-07-08
📍 Shanghai
NCT06928389 on ClinicalTrials.gov ↗
Recruiting
The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Sun Yat-sen University · started 2025-07-05
📍 Guangzhou
NCT07064681 on ClinicalTrials.gov ↗
Recruiting Phase 2
Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage
Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage Lobar
Huashan Hospital · started 2025-06-18
📍 Beijing · Chengdu · Shanghai
NCT07026994 on ClinicalTrials.gov ↗
Recruiting
Implementation of Machine Learning and Hemodynamic Profiles Based Clinical Decision Support Systems for Personalized Guideline Accordant Antihypertensive Regimens in Primary Care: a Pragmatic Cluster Randomized Controlled Trial
Hypertension
China National Center for Cardiovascular Diseases · started 2025-05-26
📍 Shenzhen
NCT06828692 on ClinicalTrials.gov ↗
By invitation
Efficacy and Safety of DS8201 in Metastatic Breast Cancer's Treatment
Breast Cancer Metastatic, Efficacy and Safety
The First Hospital of Jilin University · started 2025-05-25
📍 Changchun
NCT06914661 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd · started 2025-05-14
📍 Wuxi · Tianjin
NCT06970119 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Fudan University · started 2025-05-13
📍 Shanghai
NCT07105592 on ClinicalTrials.gov ↗
Recruiting
Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC
Medullary Thyroid Carcinoma
Luo Yaping · started 2025-05-10
📍 Beijing
NCT07138716 on ClinicalTrials.gov ↗
Recruiting
PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy
Prostate Cancer Screening, PSMA-PET
First Affiliated Hospital of Fujian Medical University · started 2025-05-07
📍 Fuzhou
NCT06923657 on ClinicalTrials.gov ↗
Active
A Randomized Controlled Trial of Robotic Support for Enhanced Later Life (RoSELL)
Loneliness, Well-Being, Psychological, Depression - Major Depressive Disorder
Shanghai Jiao Tong University School of Medicine · started 2025-05-06
📍 Shanghai
NCT07102017 on ClinicalTrials.gov ↗
Recruiting Phase 3
QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.
Nasopharyngeal Cancinoma (NPC), Nasopharyngeal Cancer
Sun Yat-Sen University Cancer Center · started 2025-05-04
📍 Fuzhou · Dongguan · Foshan · Guangzhou · Zhongshan · Nanning
NCT06749899 on ClinicalTrials.gov ↗
Recruiting Phase 3
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd. · started 2025-04-30
📍 Beijing · Chongqing · Guangzhou · Shijiazhuang · Changsha · Xuzhou
NCT06937944 on ClinicalTrials.gov ↗
Recruiting Phase 2
Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC（ARMOR2501）
Lung Cancer (NSCLC)
Sun Yat-sen University · started 2025-04-20
📍 Guangzhou
NCT06924398 on ClinicalTrials.gov ↗
Recruiting
Differences in Prosocial Behaviors and Related Brain Networks in Children With Autism and Typical Development
Autism Spectrum Disorder, Healthy
Children's Hospital of Fudan University · started 2025-04-07
📍 Shanghai
NCT06908174 on ClinicalTrials.gov ↗
Active Phase 2
Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma
Lymphoma
Daihong Liu · started 2025-04-01
📍 Beijing
NCT07094477 on ClinicalTrials.gov ↗
Starting soon EARLY_Phase 1
To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)
Wet Age-related Macular Degeneration (wAMD), Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd · started 2025-03-28
📍 Xingtai · Yiwu
NCT06888492 on ClinicalTrials.gov ↗
Recruiting Phase 2
Qinqiao Yan Shu Granules for the Treatment of Acute Pharyngitis (Exterior Wind-Heat Syndrome) Phase II Clinical Trial
Acute Pharyngitis
Jianmin Pharmaceutical Group Co., LTD. · started 2025-03-26
📍 Harbin · Changsha · Changchun · Jinan · Luzhou · Tianjin
NCT06932328 on ClinicalTrials.gov ↗
Active
Ischemic Stroke Nutrition Intervention Study
Ischemic Stroke
Harbin Medical University · started 2025-03-23
📍 Harbin · Mudanjiang · Qiqihar
NCT06817512 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL)
Institute of Hematology & Blood Diseases Hospital, China · started 2025-03-03
📍 Hefei · Chongqing · Fuzhou · Guangzhou · Nanning · Guiyang
NCT06882057 on ClinicalTrials.gov ↗
Starting soon Phase 1/Phase 2
IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure
Heart Failure, Heart Failure At NYHA Stage III or IV
HELP Therapeutics Co., Ltd. · started 2025-03
📍 Nanjing
NCT06866600 on ClinicalTrials.gov ↗
Recruiting
Evaluation of the Efficacy and Safety of Fecal Microbiota Transplantation for Constipation in Parkinson's Disease
Parkinson Disease
Shanghai Zhongshan Hospital · started 2025-02-21
📍 Shanghai
NCT06388863 on ClinicalTrials.gov ↗
Recruiting
18F-mFBG PET Imaging in the Evaluation of Neuroblastoma
Neuroblastoma
First Affiliated Hospital of Zhejiang University · started 2025-02-04
📍 Hangzhou
NCT06852807 on ClinicalTrials.gov ↗
Recruiting Phase 1
Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma
B Cell Lymphoma
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd · started 2025-01-23
📍 Shanghai
NCT07093073 on ClinicalTrials.gov ↗
By invitation
A Long-term Follow-up Study in Participants Who Received CS-101
Beta-Thalassemia
CorrectSequence Therapeutics Co., Ltd · started 2025-01-18
📍 Nanning
NCT06685536 on ClinicalTrials.gov ↗
By invitation
Morphological-Gene-Clinical Phenotype Correlation Study of the Long Anterior Zonule
Long Anterior Zonules
Fuzhou Eye Hospital · started 2025-01-10
📍 Fuzhou
NCT07549711 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects
Healthy Participants
Chengdu Brilliant Pharmaceutical Co., Ltd. · started 2025-01-10
📍 Beijing
NCT06760455 on ClinicalTrials.gov ↗
Starting soon
Validation of Joint-AI in Diagnosing Pancreatic Solid Lesions
Pancreatic Cancer, Pancreatitis, Pancreatic Neuroendocine Neoplasms (pNETs), Autoimmune Pancreatitis
Huazhong University of Science and Technology · started 2025-01
📍 Wuhan
NCT06753318 on ClinicalTrials.gov ↗
Starting soon Phase 2
Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer
Gastric (Stomach) Cancer
Fudan University · started 2024-12-25
📍 Shanghai
NCT06748508 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Heart Failure, Heart Failure With Reduced Ejection Fraction
Cytokinetics · started 2024-12-19
📍 Beijing · Lanzhou · Guangzhou · Shenzhen · Luoyang · Changsha
NCT06736574 on ClinicalTrials.gov ↗
Recruiting
Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd. · started 2024-12-15
📍 Beijing · Tianjin · Wuhan · Zhengzhou
NCT07028970 on ClinicalTrials.gov ↗
Starting soon Phase 1/Phase 2
A Single-Arm, Phase Ⅰb Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLC
Lung Cancer, Non-Small Cell
Shanghai Chest Hospital · started 2024-12-15
📍 Shanghai
NCT06690671 on ClinicalTrials.gov ↗
Recruiting
Long-term Follow-up Study of BRL-101 for TDT
Thalassemia, Beta
Bioray Laboratories · started 2024-12-08
📍 Guangzhou · Shenzhen · Nanning · Changsha · Tianjin · Guangxi
NCT06298630 on ClinicalTrials.gov ↗
Recruiting
ALI & Pulmonary HA Deposition After SAH
Subarachnoid Haemorrhage (SAH)
Tianjin Medical University · started 2024-12-01
📍 Tianjin
NCT06628531 on ClinicalTrials.gov ↗
Recruiting
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
Retinopathy of Prematurity (ROP)
Wang Yusheng · started 2024-11-29
📍 Xi'an · Xianyang
NCT06717412 on ClinicalTrials.gov ↗
Recruiting
nTMS for Negative Symptom in Schizophrenia
Schizophrenia
Central South University · started 2024-11-22
📍 Changsha
NCT06642675 on ClinicalTrials.gov ↗
Recruiting
The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer
Breast Cancer
Shengjing Hospital · started 2024-11-15
📍 Shenyang
NCT06690645 on ClinicalTrials.gov ↗
Recruiting
Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients
Peripheral T-cell Lymphoma
The First Affiliated Hospital of Soochow University · started 2024-11-01
📍 Suzhou
NCT07072221 on ClinicalTrials.gov ↗
Starting soon Phase 4
Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody
Thyroid Abnormalities, Pregnant Woman, Pregnancy Outcomes
Yang ZHANG · started 2024-10-25
📍 Shijiazhuang
NCT06653907 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Metastatic Non-small Cell Lung Cancer
AstraZeneca · started 2024-10-04
📍 Baoding · Beijing · Bengbu · Changchun · Changsha · Chengdu
NCT06417814 on ClinicalTrials.gov ↗
Recruiting Phase 2
Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC
NSCLC (Non-small Cell Lung Cancer)
Second Affiliated Hospital, Zhejiang University, School of Medicine · started 2024-10-01
📍 Hangzhou
NCT06863506 on ClinicalTrials.gov ↗
Active Phase 2
Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma
Gastric Cancer, Gastro Esophageal Junction Cancer
Fudan University · started 2024-09-30
📍 Shanghai
NCT06447636 on ClinicalTrials.gov ↗
Active Phase 3
A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation
Leber Hereditary Optic Neuropathy (LHON)
Wuhan Neurophth Biotechnology Limited Company · started 2024-09-19
📍 Beijing
NCT07406854 on ClinicalTrials.gov ↗
Starting soon
Mobile Phone-Based Smoking-Cessation Intervention for Smoking Parents
Smoking Cessation
Beijing Normal University · started 2024-09-01
📍 Zhuhai
NCT06570122 on ClinicalTrials.gov ↗
Recruiting
Continuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients
Pulmonary Hypertension
RenJi Hospital · started 2024-09-01
📍 Shanghai
NCT07149935 on ClinicalTrials.gov ↗
Recruiting
Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University · started 2024-09-01
📍 Nanchang
NCT06751940 on ClinicalTrials.gov ↗
Starting soon
Incisional Negative Pressure Therapy to Prevent Animal Induced Wound Infection
Injury Caused by Animal Bites, Wound Infection
Peking University First Hospital · started 2024-08-20
📍 Beijing
NCT06558942 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Phase I Study of LX22001 for Injection in Healthy Subjects
Healthy
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. · started 2024-08-05
📍 Beijing
NCT06561542 on ClinicalTrials.gov ↗
Active Phase 2
Iptacopan in Patients With ANCA Associated Vasculitis
Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
Novartis Pharmaceuticals · started 2024-08-05
📍 Shijiazhuang · Zhengzhou · Beijing
NCT06388941 on ClinicalTrials.gov ↗
Recruiting
Study on the Trans-Carotid Artery Occlusion Shunt System Combined With Introducer Sets
Carotid Artery Stenosis, Carotid Artery Diseases
Shenzhen Wecan Medical Technology Co.,Ltd · started 2024-07-01
📍 Beijing
NCT06959628 on ClinicalTrials.gov ↗
Recruiting
Resting Energy Expenditure and Substrate Consumption in Cardiac Arrest Patients Under Target Temperature Management
Targeted Temperature Management, Cardiac Arrest, Resting Energy Expenditure, Nutrition
Tang Ziren · started 2024-06-01
📍 Beijing
NCT06575101 on ClinicalTrials.gov ↗
By invitation
Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation
Breast Carcinoma, BRCA Mutation, Adjuvant Drug Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · started 2024-05-06
📍 Beijing
NCT06405295 on ClinicalTrials.gov ↗
Recruiting
A Cohort Study on Early Stages of Heart Failure
Stages of Heart Failure
Shanghai East Hospital · started 2024-04-15
📍 Shanghai
NCT06673615 on ClinicalTrials.gov ↗
Recruiting Phase 2
Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients
Post-stroke Cognitive Impairment
Simcere Pharmaceutical Co., Ltd · started 2024-04-08
📍 Fuyang · Hefei · Huangshan City · Guangzhou · Wuzhou · Shijiazhuang
NCT06315231 on ClinicalTrials.gov ↗
Recruiting
Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer
Colorectal Cancer
Sir Run Run Shaw Hospital · started 2024-04-08
📍 Hanzhou
NCT06167967 on ClinicalTrials.gov ↗
Recruiting Phase 2
Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases
Colorectal Cancer, Immunotherapy, Radiotherapy, Targeted Therapy
Shandong Cancer Hospital and Institute · started 2024-04-01
📍 Jinan
NCT06356584 on ClinicalTrials.gov ↗
Starting soon Phase 1
A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma, B-cell
Sinocelltech Ltd. · started 2024-04
📍 Beijing · Zhengzhou · Tianjin
NCT06318884 on ClinicalTrials.gov ↗
Recruiting Phase 4
Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)
Aneurysmal Subarachnoid Hemorrhage
Second Affiliated Hospital of Nanchang University · started 2024-03-28
📍 Hefei · Heihe · Fuzhou · Guangzhou · Harbin · Zhengzhou
NCT06284642 on ClinicalTrials.gov ↗
Recruiting
Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy
Epilepsy, Drug Resistant
Xuanwu Hospital, Beijing · started 2024-02-14
📍 Beijing
NCT06248333 on ClinicalTrials.gov ↗
Recruiting
aiTBS for NSSI and Suicide in Adolescent Depression
Non Suicidal Self Injury, Suicidal Ideation, Suicide and Self-harm
Central South University · started 2024-01-18
📍 Dali · Changsha
NCT06210100 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors
Advanced Solid Tumor
Shanghai Junshi Bioscience Co., Ltd. · started 2024-01-03
📍 Shanghai
NCT06139211 on ClinicalTrials.gov ↗
Recruiting
Early Warning and Intervention Mechanism of Foot Health Risk in Children and Adolescents
Flexible Flatfoot
Nanfang Hospital, Southern Medical University · started 2024-01-01
📍 Guangzhou
NCT06581978 on ClinicalTrials.gov ↗
Recruiting Phase 2
Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia
Relapsed/Refractory Large Granular T Lymphocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, China · started 2023-12-03
📍 Hefei · Zhoukou · Tianjin
NCT06224257 on ClinicalTrials.gov ↗
Recruiting
Application Evaluation Research on the Artificial Intelligence-assisted Support System for the Diagnosis of Colorectal Tubular Adenoma Lesions
Colorectal Adenoma, Artificial Intelligence (AI)
Renmin Hospital of Wuhan University · started 2023-11-28
📍 Wuhan
NCT07073430 on ClinicalTrials.gov ↗
Active
Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant
Diabetic Macular Edema
AbbVie · started 2023-10-30
📍 Shenzhen · Wuhan · Xi'an · Qingdao · Chengdu
NCT05978622 on ClinicalTrials.gov ↗
Recruiting Phase 2
Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma
Relapsed Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma
Navy General Hospital, Beijing · started 2023-10-30
📍 Beijing
NCT06190067 on ClinicalTrials.gov ↗
Starting soon Phase 2
Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients
Advanced Non-squamous Non-small-cell Lung Cancer, Recurrent Non-Squamous Non-Small Cell Lung Cancer, Metastatic Non-squamous Non Small Cell Lung Cancer
Peking University First Hospital · started 2023-10
📍 Beijing
NCT06028633 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD
Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd. · started 2023-09-11
📍 Beijing
NCT06707753 on ClinicalTrials.gov ↗
Recruiting
Quality Control of Ultrasound Images During Early Pregnancy Via AI
Early Pregnancy
Chinese Academy of Sciences · started 2023-09-01
📍 Beijing · Changsha
NCT06002412 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
Maximal Tumor Eradication for Oligometastatic Prostate Cancer
Oligometastatic Prostate Cancer
RenJi Hospital · started 2023-08-20
📍 Shanghai
NCT06972511 on ClinicalTrials.gov ↗
Starting soon Phase 4
Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer
Breast Cancer, Chemotherapy-induced Nausea and Vomiting
Second Affiliated Hospital, Zhejiang University, School of Medicine · started 2023-07
📍 Hanzhou
NCT05841849 on ClinicalTrials.gov ↗
Recruiting
Safety and Efficacy of Two-step Radical Prostatectomy
Prostate Cancer
Sun Yat-sen University · started 2023-02-15
📍 Guangzhou
NCT05722392 on ClinicalTrials.gov ↗
Active Phase 2
Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004)
Non Small Cell Lung Cancer Metastatic
Peking Union Medical College Hospital · started 2023-02-01
📍 Beijing
NCT05599789 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study of Comparing of With and Without Sequential Therapy of S-1
Locally Advanced Gastric Adenocarcinoma, Chemotherapy Effect
Zhejiang University · started 2023-01-28
📍 Hanzhou
NCT05813015 on ClinicalTrials.gov ↗
Recruiting
Thrombus Imaging and Treatment Analytics in Neurology
Thrombus, Brain, Thrombosis
Chinese PLA General Hospital · started 2022-12-15
📍 Beijing
NCT05663281 on ClinicalTrials.gov ↗
Recruiting Phase 2
Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
IMMUNOTHERAPY, Neoadjuvant Therapy, Resectable Lung Non-Small Cell Carcinoma, Biomarkers / Blood
Shandong Cancer Hospital and Institute · started 2022-12-02
📍 Jinan
NCT06241807 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC
High-risk NMIBC
Shanghai Hengrui Pharmaceutical Co., Ltd. · started 2022-11-23
📍 Beijing
NCT05410730 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors
Solid Tumor
Guangzhou Gloria Biosciences Co., Ltd. · started 2022-10-31
📍 Beijing
NCT05909436 on ClinicalTrials.gov ↗
Active
Efficacy of Acupuncture Treatment for Breast Cancer-associated Insomnia
Breast Neoplasms, Insomnia
Yin Ping · started 2022-10-20
📍 Shanghai
NCT05510700 on ClinicalTrials.gov ↗
Recruiting
APP-based Precise Management System of Chronic Intractable Pain
Pain, Chronic, Pain, Intractable
Beijing Tsinghua Chang Gung Hospital · started 2022-09-26
📍 Beijing
NCT05761392 on ClinicalTrials.gov ↗
Active
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
Primary Hypercholesterolemia, Mixed Dyslipidemia
Novartis Pharmaceuticals · started 2022-09-12
📍 Shenzhen
NCT05399992 on ClinicalTrials.gov ↗
Recruiting
3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
Cirrhosis, Liver, Portal Hypertension, Advanced Chronic Liver Disease
Shengjing Hospital · started 2022-08-16
📍 Shenyang
NCT05475015 on ClinicalTrials.gov ↗
Recruiting Phase 4
A Study for the Adjuvant Treatment of Breast Cancer
Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine · started 2022-07-10
📍 Hangzhou
NCT05420467 on ClinicalTrials.gov ↗
Recruiting
Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)
Acute Aortic Syndrome, Aortic Dissection Type a
Nanjing Medical University · started 2022-07-01
📍 Bengbu · Guangzhou · Nanjing · Yangzhou · Jinan · Chengdu
NCT05339529 on ClinicalTrials.gov ↗
Recruiting
Surgery vs Biologics for Treating Stricturing CD--a RCT
Crohn Disease
Zhu Weiming · started 2022-06-09
📍 Nanjing
NCT05421455 on ClinicalTrials.gov ↗
Recruiting
Research on Potential Biomarkers of Prediabetes and Diabetes Based on MALDI-TOF MS Platform.
Prediabetes, Diabetes Mellitus, Gestational Diabetes Mellitus, Proteomics
Zhujiang Hospital · started 2022-05-20
📍 Guangzhou
NCT06097065 on ClinicalTrials.gov ↗
Recruiting
A National Registry on Chinese Patients With Cystic Fibrosis
Pulmonary Function
Peking Union Medical College Hospital · started 2022-04-01
📍 Beijing
NCT05289245 on ClinicalTrials.gov ↗
Recruiting
A Prospective Cohort Study On Change of Cognitive Function In Aged-related Hearing Loss With Hearing Aids
Age-related Hearing Loss, Hearing Loss, Sensorineural, Hearing Aid, Cognitive Function Abnormal
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · started 2022-03-09
📍 Guangzhou
NCT05694039 on ClinicalTrials.gov ↗
By invitation Phase 3
A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Stereotypical Prolonged Seizures
UCB Biopharma SRL · started 2022-02-03
📍 Beijing · Changchun · Chengdu · Chongqing · Fuzhou · Guangzhou
NCT05076617 on ClinicalTrials.gov ↗
Active Phase 1
A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)
Gastrointestinal Stromal Tumors
Taiho Pharmaceutical Co., Ltd. · started 2021-12-01
📍 Beijing · Shanghai
NCT05245968 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Myasthenia Gravis
Janssen Research & Development, LLC · started 2021-07-15
📍 Beijing · Changchun · Changsha · Chengdu · Fuzhou · Guangzhou
NCT04951622 on ClinicalTrials.gov ↗
Active Phase 1
Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies
Mature B-cell Malignancies
BeiGene · started 2021-07-05
📍 Beijing · Guangzhou · Shenzhen · Zhengzhou · Wuhan · Changsha
NCT04883957 on ClinicalTrials.gov ↗
Recruiting Phase 3
Different Immunosuppressive Treatment in iMN
Idiopathic Membranous Nephropathy
Peking Union Medical College Hospital · started 2021-04-14
📍 Beijing
NCT04745728 on ClinicalTrials.gov ↗
Active Phase 2
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
Solid Tumors
Hoffmann-La Roche · started 2021-01-18
📍 Beijing · Chengdu · Shanghai · Tianjin · Xi'an
NCT04589845 on ClinicalTrials.gov ↗
Recruiting
Quinoa Improves Glycolipid Metabolism and Glucose Fluctuation Based on β-Cell Function in Early-stage Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)
Qilu Hospital of Shandong University · started 2021-01-10
📍 Jinan
NCT07329231 on ClinicalTrials.gov ↗
Active Phase 2
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche · started 2020-11-27
📍 Changchun · Guangzhou · Linyi · Nanchang · Shanghai · Tianjin
NCT04576455 on ClinicalTrials.gov ↗
Active Phase 2/Phase 3
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Karyopharm Therapeutics Inc · started 2020-09-03
📍 Nanjing · Suzhou · Huangpu · Xuhui · Chengdu · Hangzhou
NCT04442022 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
Medullary Thyroid Cancer
Loxo Oncology, Inc. · started 2020-02-11
📍 Hefei · Beijing · Chongqing · Fuzhou · Lanzhou · Guangzhou
NCT04211337 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)
Takayasu Arteritis (TAK)
AbbVie · started 2020-02-04
📍 Beijing · Guangzhou · Shenzhen · Shenyang · Shanghai
NCT04161898 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)
Follicular Lymphoma and Marginal Zone Lymphoma
Beijing Mabworks Biotech Co., Ltd. · started 2019-11-28
📍 Beijing
NCT04110301 on ClinicalTrials.gov ↗
Recruiting Phase 3
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
Rectal Cancer
Sun Yat-sen University · started 2018-11-16
📍 Guangzhou
NCT03671252 on ClinicalTrials.gov ↗
Recruiting
A National Registry on Chinese Patients With Lymphangioleiomyomatosis
Pulmonary Function
Peking Union Medical College Hospital · started 2017-01-01
📍 Beijing
NCT03193892 on ClinicalTrials.gov ↗
No trials match your search.

Browse by location

Beijing · 65 Guangzhou · 30 Shanghai · 28 Fuzhou · 14 Chengdu · 14 Changsha · 13 Shenzhen · 12 Hangzhou · 11 Tianjin · 10 Wuhan · 9 Chongqing · 8 Changchun · 7

Browse by condition

Breast Cancer · 5 Artificial Intelligence (AI) · 2 Healthy · 2 Aneurysmal Subarachnoid Hemorrhage · 2 Prostate Cancer · 2 Nasopharyngeal Cancinoma (NPC) · 2 Solid Tumors · 2 Healthy Participants · 2 Ischemic Stroke · 2 Wet Age-related Macular Degenerat… · 2 Plaque Psoriasis · 2 Solid Tumor · 2 Colorectal Cancer · 2 Gastric Cancer · 2 Lung Cancer (NSCLC) · 2 Pulmonary Function · 2
Cite this page

Priya Life Science (2026). Clinical Trials in China Tracker. Available at: https://priyalifescience.com/clinical-trials-china (Accessed: 12 August 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Chinese site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.